tesaglitazar protective_against glucose

Subject: tesaglitazar
Relation: protective_against
Object: glucose
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013) PMID:24285952 cited

This dose gives a close to maximal plasma glucose ... lowering in ob/ob mice.

confidence: 0.90